AUS
NZ
UK
CA
USA
IND
Healthcare
Is Conavi Medical Corp. Revolutionizing Market Liquidity with ICP Securities?
October 22, 2024 05:20 PM EDT| By Team Kalkine MediaHighlights:,Conavi Medical Corp. specializes in cardiovascular imaging technology.,The company has engaged ICP Securities Inc. to provide automated market making services.,The agreement between Conavi Medical and ICP starts from October 2024.,Conavi...
Can CardiolRx Transform Pericarditis Treatment?
October 22, 2024 04:51 PM EDT| By Team Kalkine MediaHighlights,Cardiol Therapeutics announces expansion of MAVERIC clinical program with MAVERIC-2 trial.,The trial will investigate CardiolRx in patients with recurrent pericarditis who discontinued IL-1 blocker therapy.,The study aims to support an acc...
Is Carebook Technologies Inc. Struggling Despite Good Indicators?
October 22, 2024 01:15 PM EDT| By Team Kalkine MediaHighlights,Carebook Technologies Inc.,(TSXV:CRBK),has experienced a significant share price drop recently.,The company's price-to-sales ratio is notably lower than many in the Healthcare Services sector.,Despite recent challenges, Carebook Technologi...
Could Current FDA-Approved Neuropathic Pain Drugs Be Falling Behind?
October 21, 2024 03:30 PM PDT| By Team Kalkine MediaHighlights:,MIRA Pharmaceuticals develops Ketamir-2, a novel oral ketamine analog.,Preclinical studies show Ketamir-2 surpasses FDA-approved treatments Gabapentin and Pregabalin for neuropathic pain.,Ketamir-2 is non-habit forming and aims to avoid s...
Is Innovotech's Keystone Labs Deal a Cause for Worry in the Healthcare Industry?
October 21, 2024 01:04 PM EDT| By Team Kalkine MediaHighlights,Innovotech Inc. plans to acquire Keystone Labs Inc., enhancing their contract-testing capabilities.,Keystone, based in Edmonton, specializes in analytical and microbiological testing services for various sectors.,The acquisition is expecte...
Could Ventripoint's Financing Exemption Raise Concerns?
October 18, 2024 04:22 PM EDT| By Team Kalkine MediaHighlights:,Ventripoint Diagnostics Ltd. recently completed a private placement offering.,The company raised gross proceeds through the issuance of units without a hold period on shares.,Deadlines for additional offerings have been extended, pending...
Voyageur Pharmaceuticals Ltd (TSX-V:VM) Launches C$1M Private Placement to Fund Growth Initiatives
October 18, 2024 01:13 AM EDT| By Team Kalkine MediaHighlights:,Voyageur Pharmaceuticals aims to raise C$1 million through a non-brokered private placement of 16.67 million units.,Each unit includes a common share and a warrant, promoting shareholder engagement and potential future capital.,Funds will...
Why Is Andlauer Healthcare Group Facing Declining Returns?
October 17, 2024 05:03 PM EDT| By Team Kalkine MediaHighlights:,Andlauer Healthcare Group operates in the healthcare logistics sector.,The company's return on capital employed (ROCE) has shown a positive trend.,Growth in the capital employed suggests the business is reinvesting effectively.,The health...
What Does Sienna's Latest Debenture Offering Mean for Its Future Growth?
October 17, 2024 03:44 PM EDT| By Team Kalkine MediaHighlights:,Sienna Senior Living Inc. completes offering of senior unsecured debentures.,The debentures bear interest and mature in the coming years.,Proceeds will be used to manage debt and corporate operations.,Sienna Senior Living Inc.,(TSX:SIA),o...
Can Voyageur's Funding Boost Innovation Ahead?
October 17, 2024 03:18 PM EDT| By Team Kalkine MediaHighlights,Voyageur Pharmaceuticals announces private placement to raise capital.,Funds to support marketing, product testing, and fullerene research.,Subscription open to existing shareholders until late November.,Voyageur Pharmaceuticals Ltd., a co...
Is Chartwell Retirement Residences Making Smart Use of Debt?
October 17, 2024 01:23 PM EDT| By Team Kalkine MediaHighlights:,Chartwell Retirement Residences operates within the retirement and senior care sector.,The company carries debt, a common aspect for businesses in this industry.,Understanding the impact of debt is crucial in assessing the stability of co...
Bright Minds Biosciences Responds to Unusual Market Activity
October 16, 2024 06:40 PM EDT| By Team Kalkine MediaHighlights,Bright Minds Biosciences responds to unusual market activity.,No significant operational changes reported by the company.,Statement released to ensure regulatory compliance and transparency.,Bright Minds Biosciences, a company in the,Healt...
Can Bright Minds Biosciences Sustain Its Stock Surge?
October 16, 2024 03:16 PM EDT| By Team Kalkine MediaHighlights,Bright Minds Biosciences' stock shows significant upward movement.,The company has extended its financial runway by focusing on cash burn reduction.,Bright Minds Biosciences operates debt-free, allowing for more strategic financial managem...
Is Dentalcorp Falling Behind Healthcare Rivals?
October 16, 2024 01:48 PM EDT| By Team Kalkine MediaHighlights,Dentalcorp Holding revenue growth lags behind industry peers.,The healthcare sector continues to see varied performance in Canada.,Dentalcorp's P/S ratio suggests expectations for moderate growth.,Dentalcorp Holdings Ltd., operating within...
Knight Therapeutics Inc. (TSX: GUD) Secures Regulatory Approval for Minjuvi® in Mexico: A New Hope for DLBCL Patients
October 16, 2024 01:48 AM EDT| By Team Kalkine MediaKey Highlights:,Knight Therapeutics' Minjuvi® receives approval for relapsed or refractory DLBCL patients not eligible for stem cell transplantation.,The L-MIND trial shows promising results with a 60% objective response rate for Minjuvi® combined wi...
BriaCell Therapeutics (TSX: BCT) Pivotal Phase 3 Study Update: Progress in Metastatic Breast Cancer Treatment
October 16, 2024 01:43 AM EDT| By Team Kalkine MediaKey Highlights:,BriaCell’s Bria-IMT™ shows promise in combination with immune checkpoint inhibitors for metastatic breast cancer.,Enrollment for the Phase 3 study is on track for completion by mid-2025, involving up to 354 patients.,Interim data anal...
How Will Aurora Spine's Hydra Osteo Onyx Lumbar System Impact Spinal Health?
October 15, 2024 05:23 PM EDT| By Team Kalkine MediaHighlights:,Aurora Spine Corporation operates in the medical device sector, focusing on spinal surgery advancements.,The company has introduced the OSTEO ONYX™ lumbar fusion system, designed for improved outcomes in complex spine cases.,The new syste...
What Could Ventripoint's Private Placement Extension Mean for the Market?
October 15, 2024 05:11 PM EDT| By Team Kalkine MediaHighlights,Ventripoint Diagnostics Ltd. focuses on developing cardiovascular diagnostic tools.,The company extended the timeline for its private placements for convertible debentures and units.,The LIFE Offering size has been increased to meet growin...
What Does the Minjuvi® Approval Mean for Knight Therapeutics in Mexico?
October 15, 2024 04:59 PM EDT| By Team Kalkine MediaHighlights,Knight Therapeutics' Mexican affiliate secures regulatory approval for Minjuvi® treatment.,Minjuvi® targets relapsed or refractory diffuse large B-cell lymphoma (DLBCL).,The treatment offers a chemo-free option for patients ineligible for...
GeneTether Therapeutics Inc. (CSE: GTTX): Exclusive Licensing Agreement for STS-201 and Upcoming Private Placement
October 15, 2024 01:09 AM EDT| By Team Kalkine MediaHighlights,GeneTether enters exclusive licensing agreement for STS-201, targeting soft tissue sarcoma and other cancers.,The company plans a private placement to raise up to C$500,000 to support the STS-201 program.,John Rothman appointed as Chief Sc...
